Transaction Details

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $634.21 to $634.42, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. | On March 10, 2025, the Reporting Person's spouse transferred 2,510 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and children are beneficiaries.